Moolec Science shareholders approve liquidation with 98.4% of votes
Shareholders of Moolec Science SA, the biotech company that sought to become an agribusiness "unicorn" and at one point exceeded a US$1 billion valuation, approved its voluntary liquidation at a virtual extraordinary meeting, with about 98.4% of votes cast, according to the Form 6-K filed with the SEC. A total of 1,408,171 ordinary shares out of 2,080,437 entitled to vote were represented (67.686%). Cassandra Ronaldson and Amiel Gottlieb, of Interpath (Cayman) Limited, were also appointed as joint voluntary liquidators.
In 40 seconds
- The voluntary liquidation was approved with about 98.4% of votes cast at a virtual extraordinary meeting.
- A total of 1,408,171 ordinary shares out of 2,080,437 entitled to vote were represented, or 67.686%.
- Cassandra Ronaldson and Amiel Gottlieb, of Interpath (Cayman) Limited, were appointed joint voluntary liquidators, also with about 98.4% support.
Read the full story at La Nación
IASummary generated by artificial intelligence from a story by La Nación. It may contain errors: the original source prevails.
Comments
Be respectful. Comments reported by several people are hidden until a moderator reviews them.
You do not need an account to read, only to comment. Sign in with a code sent to your email or with your Google account. We only show the name you choose, never your email.